000 | 01009 a2200289 4500 | ||
---|---|---|---|
005 | 20250515095130.0 | ||
264 | 0 | _c20071227 | |
008 | 200712s 0 0 eng d | ||
022 | _a0090-3493 | ||
024 | 7 |
_a10.1097/01.CCM.0000295462.58780.A5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan Westerloo, David J | |
245 | 0 | 0 |
_aA small step forward on a long way to go. _h[electronic resource] |
260 |
_bCritical care medicine _cDec 2007 |
||
300 |
_a2874-5 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aEnzyme Inhibitors _ximmunology |
650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPancreatitis _ximmunology |
773 | 0 |
_tCritical care medicine _gvol. 35 _gno. 12 _gp. 2874-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.CCM.0000295462.58780.A5 _zAvailable from publisher's website |
999 |
_c17558193 _d17558193 |